NCT01002092 A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma Status UNKNOWN Phase PHASE2
NCT00978471 Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma Status COMPLETED Phase PHASE2
NCT00931931 HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Status COMPLETED Phase PHASE1
NCT00899275 Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Status COMPLETED Phase N/A
NCT00840047 Methionine PET/CT Studies In Patients With Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00752206 A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung Status TERMINATED Phase PHASE2
NCT00743509 A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma Status COMPLETED Phase PHASE2
NCT00743496 A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma Status COMPLETED Phase PHASE1
NCT00691236 Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma Status UNKNOWN Phase PHASE2/PHASE3
NCT00689195 Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00686738 Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients Status COMPLETED Phase N/A
NCT00673179 Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy Status TERMINATED Phase NA
NCT00667342 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Status COMPLETED Phase PHASE2
NCT00634504 Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze Status COMPLETED Phase PHASE1
NCT00634322 High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma Status TERMINATED Phase PHASE2
NCT00617890 A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) Status TERMINATED Phase PHASE2